Preventive effects of turmeric (Curcuma longa Linn.) powder on hepatic steatosis in the rats fed with high fat diet

Life Science Journal

Volumn 9, Issue 4, 2012, Pages 5462-5468

  Kaffashi Elahi, Ramin ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Hepatic steatosis; High fat fed diet; Turmeric (Curcuma longa Linn.)

Indexed keywords

CURCUMA LONGA; RATTUS; RATTUS NORVEGICUS;

EID: 84877049792     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000;45:1929-1934.
2. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122:1649-1657.
3. Hokanson JE. Hypertriglyceridemia and risk of coronary heart disease, Curr Cardiol Rep 2002;4:488-493.
4. Kametani T, Koshida H, Nagaoka T, Miyakoshi H. Hypertriglyceridemia is an independent risk factor for development of impaired fasting glucose and diabetes mellitus: a 9-year longitudinal study in Japanese. Intern Med 2002;41:516-521.
5. Walldius G, Aastveit A, Jungner I. Hypercholesterolemia and hypertriglyceridemia-greatest cardiac risk in subjects with high apoB/apoAI levels. Int Congr Ser 2004;1262:203-206.
6. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118:829-838.
7. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-1351.
8. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
9. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002;17:S186-190.
10. Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region. J Gastroenterol Hepatol 2003;18:124-138.
11. James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999;353:1634-1636.
12. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 2007;47:143-183.
13. Day CP. From fat to inflammation. Gastroenterology 2006;130:207-210.
14. Day CP, James OF. Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998;114:842-845.
15. Barbuio R, Milanski M, Bertolo MB, Saad MJ, Vellosa LA. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol 2007;194:539-550.
16. Angulo P. Non-alcoholic fatty liver disease. N Engl J Med 2002;18(346):1221-1231.
17. Govindrajan VS. Turmeric chemistry, technology and quality. CRC Crit. Rev Food Sci 1980;12:199-301.
18. Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991;57:1-7.
19. Srimal RC, Dhawan BN. Pharmacology of diferuloylmethane (curcumin), a non-steroidal antiinfammatory agent. J Pharm Pharmacol 1973;25:447-452.
20. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol 1976;25:1811-1812.
21. Sreejayan N, Rao MN. Curcuminiods as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 1994;46:1013-1016.
22. Nagabhushan M, Bhide SV. Antimutagenic and anticarcinogenic action of turmeric (Curcuma longa). J Nutr Growth Cancer 1987;4:82-89.
23. Azuine MA, Bhide SV. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer 1992;17:77-83.
24. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal and colon carcinogenesis in mice. Cancer Res 1994;54:5841-5847.
25. Deshpande SS, Ingle AD, Maru GB. Inhibitory effects of curcumin-free aqueous turmeric extract on benzo(a)pyrene-induced forestomach papillomas in mice. Cancer Lett 1997;118:79-85.
26. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occuring plant phenolic compound. Cancer Res 1995;55:259-266.
27. Babu P. Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 1997;166:169-175.
28. Suryanarayana P, Saraswat M, Mrudula T, Krishna P, Krishnaswamy K, Reddy G. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci 2005;46:2092-2099.
29. Babu P. Srinivasan K. Amelioration of renal lesions associated with diabetes by dietery curcumin in streptozotocin induced diabetic rats. Mol Cell Biochem 1998;181:87-96.
30. Sajithlal GB, Chithra P, Gowri C. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 1998;56:1607-1614.
31. Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L) suppress and increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem 2005;53:959-963.
32. Mahesh T, Balasubashini M, Menon V. Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. J Med Food 2005;8:251-255.
33. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol 1978;43:86-92.
34. Bhavani Shankar TN, Shanta NV, Ramesh HP, Indira Murthy AS, Sreenivasmurthy V. Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs and monkeys. Ind J Exp Biol 1980;18:73-75.
35. Sambaiah K, Ratankumar S, Kamanna VS, Satyanarayana MN, Rao MVL. Infuence of turmeric and curcumin on growth, blood constituents and serum enzymes in rats. J Food Sci Technol 1982;19:187-190.
36. Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y, Zhang L, Wang Y. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sciences 2006;79:1100-1107.
37. Sheng L, Qian Z, Zheng S, Xi L. Mechanism of hypolipidemic effect of crocin in rats: Crocin inhibits pancreatic lipase. Eur J Pharmacol 2006;543(1-3):116-122.
38. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am J Clin Pathol 1957;28:56-63.
39. Martinek RG. A rapid ultraviolet spectrophotometric lactic dehydrogenase assay. Clin Chem Acta 1972;40(1):91-99.
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
41. Malloy HT, Evelyn KA. The determination of bilirubin level with the photoelectric colorimeter. J Biol Chem 1937;119(2):481-484.
42. Esterbauer H, Cheesman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421.
43. Nishikimi M, Rao NA, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulphate and molecular oxygen. Biochem Biophys Res Commun 1972;46:849-854.
44. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21(2):130-132.
45. Claiborne A. Catalase activity. In: Boca Raton FL, editor. CRC Handbook of methods for oxygen radical research. Florida: CRC Press, Boca Raton 1985; 283-284.
46. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973;179:588-590.
47. Mohandas J, Marshall JJ, Duggin GG, Horvath JSL, Tiller DG. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Res 1984;44:5086-5091.
48. Lee G, Luna HT. Manual of histologic staining methods of the armed forces institute of pathology. Third Edition. The Blakiston Division Mc Graw. Hill Book Company 1988;32-107.
49. Shen X, Tang Y, Yang R, Yu L, Fang T, Duan JA. The protective effect of Zizyphus jujube fruit on carbon tetrachloride-induced hepatic injury in mice by anti-oxidative activities. J Ethnopharmacol 2009;122(3):555-560
50. Chidambarama J, Venkatraman AC. Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet. Food Chemical Toxicol 2010;48(8-9):2021-2029.
51. Wang JQ, Li J, Zou YH, Cheng WM, Lu C, Zhang L, Ge JF, Huang C, Jin Y, Lv XW, Hu CM, Liu LP. Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet. J Ethnopharmacol 2009;121(1):54-60.
52. Koteish A, Diehl AM. Animal models of steatohepatitis. Semin Liver Dis 2002;21:89-104.
53. Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Seminars in Diagnostic Pathology 1998;15:246-258.